XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net income (loss) $ (1,798,955) $ (42,253)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 120,207 199,246
Share-based payment compensation 38,770 21,178
Gain on debt extinguishment 0 (754,000)
Gain on litigation settlement 0 (632,600)
Loss on disposal of fixed assets 0 50,149
Amortization of debt discount on notes payable 8,992 167,293
Amortization of right of use assets 77,989 423,867
Provision for returns and doubtful accounts (54,044) 72,461
Deferred income tax provision 67,342 261,638
Changes in operating assets and liabilities:    
Accounts receivable 633,998 (103,138)
Prepaid expenses and other current assets 130,979 725,046
Contract assets 362,801 (304,231)
Inventory 7,202 7,679
Other assets 77,919 756,767
Accounts payable 191,019 (49,387)
Accrued expenses and other long-term liabilities 409,812 (476,977)
Deferred revenue (1,395,257) (653,598)
Operating lease liabilities (77,989) (552,669)
Net cash provided by (used in) operating activities (1,199,215) (883,529)
Cash flows from investing activities:    
Purchases of property and equipment 0 (142,123)
Capitalized software development costs (35,000) (30,000)
Purchase of intangible assets (3,078) (10,226)
Net cash provided by (used in) investing activities (38,078) (182,349)
Cash flows from financing activities:    
Proceeds from public offering, net of underwriting discounts paid 0 4,181,908
Payments of offering costs 0 (515,844)
Proceeds from short-term debt 253,069 0
Payments of short-term debt (75,920) (1,334,058)
Net cash provided by (used in) financing activities 177,149 2,332,006
Effect of exchange rate changes on cash and cash equivalents (110,003) (5,575)
Net increase (decrease) in cash and cash equivalents (1,170,147) 1,260,553
Cash and cash equivalents, beginning of year 3,181,209 1,920,656
Cash and cash equivalents, end of year 2,011,062 3,181,209
Supplemental Disclosures:    
Cash paid for interest 130,040 136,042
Cash paid for income taxes, net 0 0
Non-cash financing activities:    
Undistributed Series A redeemable convertible preferred stock dividends 1,494,057 1,143,697
Accretion of Series A redeemable convertible preferred stock $ 49,573 $ 299,969